The CDC meeting Tuesday emphasized COVID-19’s cost on young children, who, while less at risk than older adults, are still susceptible to disease, hospitalization and …
This is the first time government advisers have recommended routine use of a pneumococcal vaccine for certain risk groups within the 19-64 age bracket, a …
